Dive deeper: Detailed guide on how to buy stocks in Canada
AbbVie is a drug manufacturers - general business based in the US. AbbVie stocks (ABBV) are listed on the NYSE, and all prices are listed in US Dollars.
Its last market close was $230.24, which is an increase of 1.13% over the previous week. AbbVie employs 55,000 staff and has a trailing 12-month revenue of around $59.6 billion.
Keep reading to see up-to-date AbbVie stock price and performance data, along with a step-by-step guide for how to buy AbbVie stock in Canada.
AbbVie (ABBV) stock summary
| Company stock name | AbbVie Inc |
| Stock ticker symbol | ABBV |
| Exchange | NYSE |
| Open | $224.84 |
| High | $230.79 |
| Low | $224.52 |
| Close | $230.24 |
| Adjusted closing | $230.24 |
| Volume | 4,872,900 |
| 52-week stock price range | $160.33 – $243.06 | Where to buy AbbVie stock | Buy on CIBC Investor's Edge |
Can I buy AbbVie stock in Canada?
Yes, you can buy AbbVie stock in Canada. You simply need to open a brokerage account with an online trading platform that supports stocks on the NYSE exchange. Platforms like Interactive Brokers will allow you to directly buy AbbVie stock from within Canada.How to buy AbbVie stock
Follow these step-by-step instructions to purchase AbbVie (ABBV) stock in Canada:
-
Choose a stock trading platform.
Compare trading platforms. Choose a trading app with competitive pricing, access to trading tools and a user-friendly interface. (Check out our guide to the best trading apps in Canada.) -
Open a trading account.
To open a trading account, you'll need to provide personal information (like your email, phone number and banking details), verify your identity and complete the sign-up process. -
Fund your account.
Deposit funds into your trading account by linking your bank account via an Electronic Funds Transfer (EFT), wire transfer, cheque deposit or by whatever means the platform supports. Make sure you deposit enough to cover the stock price + any trading fees. -
Search for the stock—ABBV.
Look up the stock using its name (AbbVie Inc) or ticker symbol (ABBV). Review its current price, recent performance and other relevant data before placing your order. -
Complete your purchase of AbbVie stock.
Choose the number of ABBV stocks you want to purchase, place your order, confirm the details and then submit. Once executed, the shares will appear in your trading account.
Our top picks for where to buy AbbVie stock
Easy to use app
- Easy-to-use platform
- Low fees
- Student, young investor & active trader discounts
Low margin rates
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
AbbVie stock chart (NYSE: ABBV)
This chart tracks AbbVie stock price performance over time.AbbVie stock price
AbbVie's stock price at the last available market close was $230.24 (as of December 2, 2025). Keep in mind that AbbVie's stock price can be impacted on a daily, or even hourly, basis by factors like company performance, the broader economy and investor sentiments.
Is AbbVie stock a buy or sell right now?
The technical analysis gauge above shows real-time buy or sell ratings and analysis for AbbVie stock based on your selected timeframe. It uses three widely followed indicators—moving averages, oscillators and pivots—but this does not represent investment advice or a guarantee of success. Finder may not concur with these signals and accepts no responsibility for the performance of your stocks.
Can I buy AbbVie stock on the TSX?
No, you cannot buy AbbVie stock on the TSX because AbbVie stock is not listed on the TSX. Instead, AbbVie stock is listed on the NYSE under the symbol "ABBV."
That said, if you're wondering how to invest in AbbVie stock in Canada, you still have the option to do so by opening a trading account with a Canadian brokerage that gives you access to NYSE, like Interactive Brokers.
AbbVie stock dividends
AbbVie dividend payout ratio: 69.42% of net profits
Recently AbbVie has paid out, on average, around 69.42% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.04% of the current stock value.
This means that, over a year, based on recent payouts (which are sadly no guarantee of future payouts), AbbVie shareholders could enjoy a 3.04% return on their shares in the form of dividend payments. In AbbVie's case, that would currently equate to about $6.56 per share.
AbbVie's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
AbbVie's next dividend payout is expected around February 17, 2026. To benefit, you'll need to buy AbbVie stocks before January 16, 2026 (the "ex-dividend date").
AbbVie stock performance metrics
Here are some common key metrics for AbbVie stock that analysts often use to help gauge a stock's value—P/E ratio, PEG ratio and EBITDA.
How volatile is AbbVie stock?
Over the last 12 months, AbbVie's stocks price has ranged from $160.33 to as high as $243.06. AbbVie's beta measurement of stock volatility is 0.35. For comparison, the market () average beta is 1. This would suggest that AbbVie's stocks are less volatile than average (on this exchange).
Some analysists use "beta" to gauge a stock's volatility. Beta is a popular way to measure a stocks volatility in relation to the market. Here is a breakdown of AbbVie's beta stock volatility rating.
AbbVie Inc company and revenue performance
| Market Capitalization | $402.4 billion |
|---|---|
| Gross profit (TTM) | $42.6 billion |
| Operating margin (TTM) | 35.50% |
| Profit margin | 4.00% |
| Revenue (TTM) | $59.6 billion |
| Return on assets (TTM) | 9.59% |
| Return on equity (TTM) | 137.96% |
| Earnings per share (TTM) | $1.31 |
| 50-day moving stock price average | $227.54 |
| 200-day moving stock price average | $203.86 |
AbbVie company profile
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma.
It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products.
Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Compare trading platforms to buy AbbVie stock
Compare special offers, low fees and a wide range of investment options among popular trading platforms in Canada. Note that the dollar amounts in the table below are in CAD.
5 of 5 results
Finder Score for stock trading platforms
To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score, the better the platform—it's that simple.
Do I have to pay tax on gains from AbbVie stock sales in Canada?
Yes, you'll need to pay taxes in Canada on investment income, which includes any profit from selling AbbVie stock. The CRA taxes investment income from stocks in Canada based on three main factors:
- Investment income. Investment income includes money earned from interest, dividends or capital gains, which may affect how much you have to pay in taxes on stock sales in Canada.
- Investor type. Your investment income will be taxed differently depending on whether you're a regular investor or a day trader (which means you buy and trade stocks on a daily basis as your primary form of income).
- Tax bracket. The higher your tax bracket, the more you'll pay on income from stock sales. Your tax bracket depends on your gross income (minus deductions).
You can learn more about the tax implications of selling stocks in Canada here.
Frequently asked questions about AbbVie stock
Sources
Important information: Powered by Finder.com. This information is general in nature and is no substitute for professional advice. It does not take into account your personal situation. This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for most investors. You do not own or have any interest in the underlying asset. Capital is at risk, including the risk of losing more than the amount originally put in, market volatility and liquidity risks. Past performance is no guarantee of future results. Tax on profits may apply. Consider the Product Disclosure Statement and Target Market Determination for the product on the provider's website. Consider your own circumstances, including whether you can afford to take the high risk of losing your money and possess the relevant experience and knowledge. We recommend that you obtain independent advice from a suitably licensed financial advisor before making any trades.
More on investing
Stock Trading
We break down which companies hold Ethereum, why they’re doing it and what ETH treasuries mean for markets and investors.
Stock Trading
Want to invest in the Euro Stoxx 50 in Canada? Explore investment platforms and popular Euro Stoxx 50 index funds.
Stock Trading
What are the best stocks for beginners with little money to invest?
Want to dive into investing but don’t have much to spend? Take a look at these types of stocks.
More resources on Finder
More guides on Finder
-
7 alternatives to Wealthsimple in Canada
We compare seven Wealthsimple alternatives to help you find the best investing platform or day-to-day bank account.
-
7 wheat stocks to watch
Want to invest in wheat companies? We’ve put together a list of wheat stocks you should keep your eye on.
-
8 residential reit stocks to watch
Want to invest in REIT companies? We’ve put together a list of residential REIT stocks you should keep your eye on.
-
8 bnpl stocks to watch
Want to invest in buy now, pay later companies? We’ve put together a list of BNPL stocks you should keep your eye on.
-
7 trucking stocks to watch
Want to invest in trucking companies? We’ve put together a list of trucking stocks you should keep your eye on.
-
7 space stocks to watch
Want to invest in space companies? We’ve put together a list of space stocks you should keep your eye on.
-
7 oil tanker stocks to watch
Want to invest in oil tanker companies? We’ve put together a list of oil tanker stocks you should keep your eye on.
-
4 diamond stocks to watch
Want to invest in diamond companies? We’ve put together a list of diamond stocks you should keep your eye on.
-
8 sports stocks to watch
Want to invest in sports companies? We’ve put together a list of sports stocks you should keep your eye on.
-
Best renewable energy stocks
These are the best renewable energy stocks to buy now in Canada.